129 related articles for article (PubMed ID: 23831514)
1. TFII-I regulates target genes in the PI-3K and TGF-β signaling pathways through a novel DNA binding motif.
Segura-Puimedon M; Borralleras C; Pérez-Jurado LA; Campuzano V
Gene; 2013 Sep; 527(2):529-36. PubMed ID: 23831514
[TBL] [Abstract][Full Text] [Related]
2. PI3K/Akt-dependent functions of TFII-I transcription factors in mouse embryonic stem cells.
Chimge NO; Makeyev AV; Waigel SJ; Enkhmandakh B; Bayarsaihan D
J Cell Biochem; 2012 Apr; 113(4):1122-31. PubMed ID: 22274952
[TBL] [Abstract][Full Text] [Related]
3. Essential role of the N-terminal region of TFII-I in viability and behavior.
Lucena J; Pezzi S; Aso E; Valero MC; Carreiro C; Dubus P; Sampaio A; Segura M; Barthelemy I; Zindel MY; Sousa N; Barbero JL; Maldonado R; Pérez-Jurado LA; Campuzano V
BMC Med Genet; 2010 Apr; 11():61. PubMed ID: 20403157
[TBL] [Abstract][Full Text] [Related]
4. A mouse single-copy gene, Gtf2i, the homolog of human GTF2I, that is duplicated in the Williams-Beuren syndrome deletion region.
Wang YK; Pérez-Jurado LA; Francke U
Genomics; 1998 Mar; 48(2):163-70. PubMed ID: 9521869
[TBL] [Abstract][Full Text] [Related]
5. Essential functions of the Williams-Beuren syndrome-associated TFII-I genes in embryonic development.
Enkhmandakh B; Makeyev AV; Erdenechimeg L; Ruddle FH; Chimge NO; Tussie-Luna MI; Roy AL; Bayarsaihan D
Proc Natl Acad Sci U S A; 2009 Jan; 106(1):181-6. PubMed ID: 19109438
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis of Williams-Beuren syndrome: TFII-I regulated targets involved in craniofacial development.
Makeyev AV; Bayarsaihan D
Cleft Palate Craniofac J; 2011 Jan; 48(1):109-16. PubMed ID: 20500075
[TBL] [Abstract][Full Text] [Related]
7. Gene expression analysis of TFII-I modulated genes in mouse embryonic fibroblasts.
Chimge NO; Mungunsukh O; Ruddle F; Bayarsaihan D
J Exp Zool B Mol Dev Evol; 2007 May; 308(3):225-35. PubMed ID: 17094079
[TBL] [Abstract][Full Text] [Related]
8. Isolation and characterisation of GTF2IRD2, a novel fusion gene and member of the TFII-I family of transcription factors, deleted in Williams-Beuren syndrome.
Tipney HJ; Hinsley TA; Brass A; Metcalfe K; Donnai D; Tassabehji M
Eur J Hum Genet; 2004 Jul; 12(7):551-60. PubMed ID: 15100712
[TBL] [Abstract][Full Text] [Related]
9. A duplicated gene in the breakpoint regions of the 7q11.23 Williams-Beuren syndrome deletion encodes the initiator binding protein TFII-I and BAP-135, a phosphorylation target of BTK.
Pérez Jurado LA; Wang YK; Peoples R; Coloma A; Cruces J; Francke U
Hum Mol Genet; 1998 Mar; 7(3):325-34. PubMed ID: 9466987
[TBL] [Abstract][Full Text] [Related]
10. ChIP-Chip Identifies SEC23A, CFDP1, and NSD1 as TFII-I Target Genes in Human Neural Crest Progenitor Cells.
Makeyev AV; Bayarsaihan D
Cleft Palate Craniofac J; 2013 May; 50(3):347-50. PubMed ID: 23145914
[TBL] [Abstract][Full Text] [Related]
11. Intracisternal Gtf2i Gene Therapy Ameliorates Deficits in Cognition and Synaptic Plasticity of a Mouse Model of Williams-Beuren Syndrome.
Borralleras C; Sahun I; Pérez-Jurado LA; Campuzano V
Mol Ther; 2015 Nov; 23(11):1691-1699. PubMed ID: 26216516
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic modulation by TFII-I during embryonic stem cell differentiation.
Bayarsaihan D; Makeyev AV; Enkhmandakh B
J Cell Biochem; 2012 Oct; 113(10):3056-60. PubMed ID: 22628223
[TBL] [Abstract][Full Text] [Related]
13. High-throughput screening identifies histone deacetylase inhibitors that modulate GTF2I expression in 7q11.23 microduplication autism spectrum disorder patient-derived cortical neurons.
Cavallo F; Troglio F; Fagà G; Fancelli D; Shyti R; Trattaro S; Zanella M; D'Agostino G; Hughes JM; Cera MR; Pasi M; Gabriele M; Lazzarin M; Mihailovich M; Kooy F; Rosa A; Mercurio C; Varasi M; Testa G
Mol Autism; 2020 Nov; 11(1):88. PubMed ID: 33208191
[TBL] [Abstract][Full Text] [Related]
14. Hunchback sequence binding protein suppresses mouse TGF-beta3 promoter in vitro.
Yamazaki K; Crowe DL; Shuler CF
Biochem Biophys Res Commun; 2006 Aug; 346(3):802-9. PubMed ID: 16781676
[TBL] [Abstract][Full Text] [Related]
15. Chromatin immunoprecipitation on microarray analysis of Smad2/3 binding sites reveals roles of ETS1 and TFAP2A in transforming growth factor beta signaling.
Koinuma D; Tsutsumi S; Kamimura N; Taniguchi H; Miyazawa K; Sunamura M; Imamura T; Miyazono K; Aburatani H
Mol Cell Biol; 2009 Jan; 29(1):172-86. PubMed ID: 18955504
[TBL] [Abstract][Full Text] [Related]
16. Alternative splicing and promoter use in TFII-I genes.
Makeyev AV; Bayarsaihan D
Gene; 2009 Mar; 433(1-2):16-25. PubMed ID: 19111598
[TBL] [Abstract][Full Text] [Related]
17. Diversity and complexity in chromatin recognition by TFII-I transcription factors in pluripotent embryonic stem cells and embryonic tissues.
Makeyev AV; Enkhmandakh B; Hong SH; Joshi P; Shin DG; Bayarsaihan D
PLoS One; 2012; 7(9):e44443. PubMed ID: 22970219
[TBL] [Abstract][Full Text] [Related]
18. Yamanaka factors critically regulate the developmental signaling network in mouse embryonic stem cells.
Liu X; Huang J; Chen T; Wang Y; Xin S; Li J; Pei G; Kang J
Cell Res; 2008 Dec; 18(12):1177-89. PubMed ID: 19030024
[TBL] [Abstract][Full Text] [Related]
19. Identification of the TFII-I family target genes in the vertebrate genome.
Chimge NO; Makeyev AV; Ruddle FH; Bayarsaihan D
Proc Natl Acad Sci U S A; 2008 Jul; 105(26):9006-10. PubMed ID: 18579769
[TBL] [Abstract][Full Text] [Related]
20. TFII-I-mediated polymerase pausing antagonizes GLI2 induction by TGFβ.
McCleary-Wheeler AL; Paradise BD; Almada LL; Carlson AJ; Marks DL; Vrabel A; Vera RE; Sigafoos AN; Olson RL; Fernandez-Zapico ME
Nucleic Acids Res; 2020 Jul; 48(13):7169-7181. PubMed ID: 32544250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
